Your Article Summary
Merck Introduces New Strategy: BioVentures
PharmExec, 01/12/09
While some big pharma companies are in the midst of buying up biotech firms, Merck decided that it could to the job itself, announcing that it will establish a biologics division called Merck BioVentures.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
PR distribution service for the biotech industry
b3c newswire, 12/07/09
Safety First in Biotech Development
BioPharm, 12/03/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor


See Latest Articles


